from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3144c/PPE52

LFCtreatmentdescriptionclass of inhibitor

-1.451

Amikacinug/mL Amikacintranslation

-1.346

Cap5-10ug/mL Capreomycintranslation

-1.075

Rox10-50 ug/mL Roxithromycintranslation

-0.701

SM2-5 ug/mL Streptomycintranslation

-1.322

Tet5-10 ug/mL Tetracyclinetranslation

0.918

Rif0.2-5ug/mL Rifampicintranscription

-0.602

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.640

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.112

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.291

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.176

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.413

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.041

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.496

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.309

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.641

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.990

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.057

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.383

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.460

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.975

KCN5-20 ug/mL Potassium cyaniderespiration

0.615

NaN30.2-2 mM Sodium aziderespiration

-1.067

Nigericin50 uM Nigericinrespiration

-0.169

TRC10-150 ug/mL Triclosanrespiration

-0.600

TRZ10-25 ug/mL Thioridazinerespiration

-1.064

Valinomycin0.5-10 uM Valinomycinrespiration

3.477

ZnSO42 mM ZnSO4respiration

-0.642

menadione6-10 ug/mL Menadionerespiration

0.193

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.195

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.233

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.425

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.869

NRP_1Non-replicating persistence stage 1dosRassociated

-0.239

Amp0.2mg/mL AmpicillincellWall

-0.141

Cephalexin20-100 ug/mL CephalexincellWall

-0.461

Cerulenin0.32-5 ug/mL CerulenincellWall

1.114

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.522

EMB10-20 ug/mL EthambutolcellWall

-0.869

Eta12-40 ug/mL EthionamidecellWall

-0.922

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.343

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.587

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.780

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.045

BZA0.12 mg/mL BenzamidearomaticAmides

0.729

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.514

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.567

H2O24 mM hydrogen peroxideDNAdamaging

-0.895

Levo10 ug/mL LevofloxacinDNAdamaging

0.467

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.470

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.561

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.313

UVUV-irradiationDNAdamaging

-1.176

ARP41-4 ug/mL Antitubercular compound ARP4?

0.011

Antimycin12.5-50 ug/mL Antimycin A?

-0.816

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.057

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.087

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.654

PA8240.2-2 ug/mL PA-824?

-0.261

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.079

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.602

Verapamil50 uM Verapamil?

-0.710

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.891

methoxatin10-20 ug/mL Methoxatin?